½ÃÀ庸°í¼­
»óǰÄÚµå
1594495

³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå : ÇüÅÂ, »ý»ê, µî±Þ, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Niacinamide Market by Form (Granular, Liquid, Powder), Production (Natural, Synthetic), Grade, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀåÀº 2023³â 7¾ï 1,577¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 7¾ï 4,560¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 4.65% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 9¾ï 8,411¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºñŸ¹Î B3ÀÇ ÀÏÁ¾ÀÎ ³ªÀ̾ƽžƸ¶À̵å´Â ÇǺΠ°ü¸® È¿°ú°¡ ³Î¸® ¾Ë·ÁÁø ´Ù¸éÀûÀÎ ¼ººÐÀ¸·Î È­Àåǰ ¹× ÆÛ½º³ÎÄÉ¾î »ê¾÷¿¡ Å« ºÎ°¡°¡Ä¡¸¦ ºÎ¿©Çϰí ÀÖ½À´Ï´Ù. ±× Çʿ伺Àº Ç׿°Áõ, Ç׳ëÈ­, ¹Ì¹é È¿°ú·Î ÀÎÇØ ´Ù±â´É ½ºÅ²ÄÉ¾î ¼Ö·ç¼ÇÀ» ã´Â ¼ÒºñÀڵ鿡°Ô ¾îÇÊÇϰí ÀÖ½À´Ï´Ù. ³ªÀ̾ƽžƸ¶À̵å´Â ¿©µå¸§, »ö¼Ò Ä§Âø, ÇǺΠº¸½ÀÀ» ¸ñÇ¥·Î ÇÏ´Â Å©¸², ¼¼·³, ·Î¼Ç¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ë ¹üÀ§´Â ÇǺΠ°ü¸®¿¡¸¸ ±¹ÇѵÇÁö ¾Ê°í ½Å°æ°è¿Í ¼ÒÈ­±â °èÅë¿¡ ¹ÌÄ¡´Â À¯ÀÍÇÑ È¿°ú·Î ÀÎÇØ ¿µ¾ç º¸ÃæÁ¦ ¹× ÀǾàǰ¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 7¾ï 1,577¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 7¾ï 4,560¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 9¾ï 8,411¸¸ ´Þ·¯
CAGR(%) 4.65%

½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº ½ºÅ²Äɾî¿Í À£ºù¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀÎ½Ä Áõ°¡, õ¿¬ ¹× ´Ù¿ëµµ ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÇǺΠÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÔ´Ï´Ù. ºü¸£°Ô ¼ºÀåÇÏ´Â ºäƼ ¹× ÆÛ½º³ÎÄÉ¾î »ê¾÷Àº À¯±â³ó ¹× Áö¼Ó°¡´ÉÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå È®´ëÀÇ ±âÆøÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ Á¦Ç° ¶óÀο¡ ³ªÀ̾ƽžƸ¶À̵尡 ÅëÇյǸ鼭 ÇÁ¸®¹Ì¾ö ºê·£µåºÎÅÍ ´ëÁßÀûÀÎ Á¦Ç°±îÁö ´Ù¾çÇÑ ÁøÀÔÁ¡°ú »ç¿ëÀÚÃþÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù.

À¯¸ÁÇÑ Àü¸Á¿¡µµ ºÒ±¸Çϰí, ½ÃÀå ¼ºÀåÀº È­Àåǰ ó¹æÀ» µÑ·¯½Ñ ¾ö°ÝÇÑ ±ÔÁ¦¿Í »ç¿ëÀÚµéÀÇ ÀáÀçÀûÀÎ ÇǺΠ°ú¹Î¼º ¹®Á¦ µîÀÇ µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, È÷¾Ë·ç·Ð»ê, ºñŸ¹Î C µî ´ëü ¼ººÐÀÇ °æÀï ¾Ð·Âµµ ÇѰ迡 ºÎµúÈ÷°í ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷µéÀº ³ªÀ̾ƽžƸ¶À̵å¿Í º¸¿ÏÀûÀÎ ¼ººÐÀ» °áÇÕÇÑ Çõ½ÅÀûÀÎ Á¦Çü¿¡ ÁýÁßÇÏ¿© Á¦Ç°ÀÇ È¿´É°ú ¼ÒºñÀÚ ¸¸Á·µµ¸¦ ÃÖÀûÈ­ÇØ¾ß ÇÕ´Ï´Ù. Çì¾îÄɾî¿Í ³×ÀÏ Äɾ ´ëÇÑ ±¤¹üÀ§ÇÑ ÀÀ¿ëÀ» ޱ¸ÇÏ´Â ¿¬±¸¿¡ ÅõÀÚÇÏ¸é ´õ ¸¹Àº ½ÃÀå °ø°£ÀÌ ¿­¸± ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ¼ÒºñÀÚÀÇ È¯°æ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¦Ç° Á¶´Þ ¹× »ý»ê °úÁ¤ÀÇ Åõ¸í¼º°ú Áö¼Ó°¡´É¼ºÀ» °­Á¶ÇÏ¸é ºê·£µåÀÇ ½Å·Ú¿Í ¸Å·ÂÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í °æÀïÀÌ Ä¡¿­Çϸç, ±â¼ú Çõ½ÅÀº ÁÖ·Î Á¦Ç° °ø±Þ ¹æ¹ýÀÇ ¹ßÀü°ú Á¦Çü °³¼±À» ¹Ý¿µÇÕ´Ï´Ù. º¯È­ÇÏ´Â ¼ÒºñÀÚ ÃëÇâ¿¡ ´ëÀÀÇÏ°í ½ºÅ²Äɾî È¿´É Å×½ºÆ®ÀÇ ±â¼úÀû Áøº¸¸¦ Ȱ¿ëÇÏ¸é ±â¾÷Àº ÀÌ È°±âÂù ½ÃÀå °ø°£¿¡¼­ µ¶ÀÚÀûÀÎ ÀÔÁö¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ´ç´¢º´, °ñ°üÀý¿°, °íÀλêÇ÷Áõ¿¡ ´ëÇÑ ´Ï¾Æ½Å¾Æ¹Ìµå ÇÔÀ¯ ½Äǰ ¶Ç´Â º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚ ¿ä±¸
    • ³ªÀ̾ƽžƸ¶À̵尡 ÇÔÀ¯µÈ ½ºÅ²Äɾî Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • »ç·á °­È­¸¦ À§ÇÑ ³ªÀ̾ƽžƸ¶ÀÌµå »ç¿ë Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ¿ø·áÀÇ °¡¿ë¼º Á¦ÇѰú °¡°ÝÀÇ ºÒ¾ÈÁ¤¼º
  • ½ÃÀå ±âȸ
    • ¾Ï Ä¡·á¸¦ À§ÇÑ ³ªÀ̾ƽžƸ¶À̵å Ä¡·á¹ý °³¹ßÀ» À§ÇÑ ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß Ȱµ¿
    • ÀϹÝÀǾàǰ(OTC)¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ³ªÀ̾ƽžƸ¶À̵åÀÇ Àå±â »ç¿ë¿¡ µû¸¥ ºÎÀÛ¿ë°ú ¾Ë·¹¸£±â ¹ÝÀÀ

Porter's Five Forces : ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀåÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå¿¡¼­ÀÇ º¥´õÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå : Çüź°

  • ÀÔ»ó
  • ¾×ü
  • ºÐ¸»

Á¦7Àå ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå : »ý»êº°

  • õ¿¬
  • ÇÕ¼º

Á¦8Àå ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå : µî±Þº°

  • »ç·á µî±Þ
  • ÀǾàǰ µî±Þ

Á¦9Àå ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå : ¿ëµµº°

  • µ¿¹° ¿µ¾ç
  • È­Àåǰ
  • Àΰ£ ¿µ¾ç
  • ÀǾàǰ

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³ªÀ̾ƽžƸ¶ÀÌµå ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • AIE Pharmaceuticals, Inc.
  • Bio-Tech Pharmacal, Inc.
  • Evonik Industries AG
  • Fagron Inc.
  • Foodchem International Corporation
  • Gemini Pharmaceuticals
  • Glanbia PLC
  • Koninklijke DSM N.V.
  • Lasons India Pvt Ltd.
  • Lonza Group AG
  • Merck KGaA
  • NutraScience Labs
  • Spectrum Chemical Mfg. Corporation
  • Vertellus LLC
  • Western Drugs Ltd.
  • Yuki Gosei Kogyo Co., Ltd.
ksm 24.11.28

The Niacinamide Market was valued at USD 715.77 million in 2023, expected to reach USD 745.60 million in 2024, and is projected to grow at a CAGR of 4.65%, to USD 984.11 million by 2030.

Niacinamide, a form of vitamin B3, is a multifaceted ingredient widely recognized for its skincare benefits, adding significant value to the cosmetics and personal care industries. Its necessity arises from its anti-inflammatory, anti-aging, and brightening properties, appealing to consumers seeking multifunctional skincare solutions. Niacinamide finds applications in creams, serums, and lotions targeting acne, hyperpigmentation, and skin hydration. The end-use scope extends beyond skincare, encompassing dietary supplements and pharmaceutical products due to its beneficial impacts on the nervous and digestive systems.

KEY MARKET STATISTICS
Base Year [2023] USD 715.77 million
Estimated Year [2024] USD 745.60 million
Forecast Year [2030] USD 984.11 million
CAGR (%) 4.65%

Market growth is primarily driven by increasing consumer awareness of skincare and wellness, escalating demand for natural and versatile ingredients, and the rising prevalence of skin disorders. The burgeoning beauty and personal care industry, with a strong inclination towards organic and sustainable products, catalyzes the market expansion. Furthermore, the integration of niacinamide in diverse product lines fosters multiple entry points and user segments, from premium brands to mass-market offerings.

Despite its promising outlook, market growth faces challenges, including stringent regulations surrounding cosmetic formulations and potential skin sensitivity issues among users. Competitive pressures from alternative ingredients, such as hyaluronic acid and vitamin C, also pose limitations.

To capitalize on market opportunities, companies should focus on innovative formulations that combine niacinamide with complementary ingredients, ensuring optimal product efficacy and consumer satisfaction. Investing in research that explores its broader applications in hair and nail care could unlock additional market spaces. Emphasizing transparency and sustainability in product sourcing and production processes can enhance brand trust and appeal, especially amid increasing consumer environmental consciousness. The market is dynamic and highly competitive, with innovation predominantly reflecting advancements in product delivery methods and enhanced formulations. By staying attuned to evolving consumer preferences and leveraging technological advancements in skincare efficacy testing, businesses can carve out a unique position in this vibrant market space.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Niacinamide Market

The Niacinamide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
    • Increasing demand for skin care products containing niacinamide
    • Growing use of niacinamide for animal feed fortification
  • Market Restraints
    • Limited availability and volatility of the prices of ingredients
  • Market Opportunities
    • Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
    • Growing preference for Over-the-counter (OTC) cosmeceuticals
  • Market Challenges
    • Adverse side effects and allergic reactions associated with the long-term use of niacinamide

Porter's Five Forces: A Strategic Tool for Navigating the Niacinamide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Niacinamide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Niacinamide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Niacinamide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Niacinamide Market

A detailed market share analysis in the Niacinamide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Niacinamide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Niacinamide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Niacinamide Market

A strategic analysis of the Niacinamide Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Niacinamide Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc., Bio-Tech Pharmacal, Inc., Evonik Industries AG, Fagron Inc., Foodchem International Corporation, Gemini Pharmaceuticals, Glanbia PLC, Koninklijke DSM N.V., Lasons India Pvt Ltd., Lonza Group AG, Merck KGaA, NutraScience Labs, Spectrum Chemical Mfg. Corporation, Vertellus LLC, Western Drugs Ltd., and Yuki Gosei Kogyo Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Niacinamide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Granular, Liquid, and Powder.
  • Based on Production, market is studied across Natural and Synthetic.
  • Based on Grade, market is studied across Feed Grade and Pharmaceutical Grade.
  • Based on Application, market is studied across Animal Nutrition, Cosmeceuticals, Human Nutrition, and Pharmaceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
      • 5.1.1.2. Increasing demand for skin care products containing niacinamide
      • 5.1.1.3. Growing use of niacinamide for animal feed fortification
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and volatility of the prices of ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
      • 5.1.3.2. Growing preference for Over-the-counter (OTC) cosmeceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse side effects and allergic reactions associated with the long-term use of niacinamide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Niacinamide Market, by Form

  • 6.1. Introduction
  • 6.2. Granular
  • 6.3. Liquid
  • 6.4. Powder

7. Niacinamide Market, by Production

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Niacinamide Market, by Grade

  • 8.1. Introduction
  • 8.2. Feed Grade
  • 8.3. Pharmaceutical Grade

9. Niacinamide Market, by Application

  • 9.1. Introduction
  • 9.2. Animal Nutrition
  • 9.3. Cosmeceuticals
  • 9.4. Human Nutrition
  • 9.5. Pharmaceuticals

10. Americas Niacinamide Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Niacinamide Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Niacinamide Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AIE Pharmaceuticals, Inc.
  • 2. Bio-Tech Pharmacal, Inc.
  • 3. Evonik Industries AG
  • 4. Fagron Inc.
  • 5. Foodchem International Corporation
  • 6. Gemini Pharmaceuticals
  • 7. Glanbia PLC
  • 8. Koninklijke DSM N.V.
  • 9. Lasons India Pvt Ltd.
  • 10. Lonza Group AG
  • 11. Merck KGaA
  • 12. NutraScience Labs
  • 13. Spectrum Chemical Mfg. Corporation
  • 14. Vertellus LLC
  • 15. Western Drugs Ltd.
  • 16. Yuki Gosei Kogyo Co., Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦